Posterior reversible encephalopathy syndrome on 18F-FDG PET/CT in a pediatric patient with Burkitt's Lymphoma

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We present a case of posterior reversible encephalopathy syndrome (PRES) in a pediatric patient with Burkitt's lymphoma predominantly involving the bone marrow. 18F-FDG PET/CT scan obtained after the first cycle of chemotherapy, complicated by acute kidney injury, hypertension, tumor lysis syndrome, and lethargy with focal neurological symptoms, showed a favorable marrow and lymph node response but increased FDG uptake in the bilateral frontal and occipital cortical/subcortical regions. Brain MRI was consistent with PRES. The patient was managed with IV hydration and blood pressure control with symptom resolution. This case shows the 18F-FDG uptake pattern of PRES in postchemotherapy setting.

Cite

CITATION STYLE

APA

Aldin, E. S., McNeely, P., & Menda, Y. (2018). Posterior reversible encephalopathy syndrome on 18F-FDG PET/CT in a pediatric patient with Burkitt’s Lymphoma. Clinical Nuclear Medicine, 43(3), 195–198. https://doi.org/10.1097/RLU.0000000000001979

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free